v3.26.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Common Stock
Pre-funded warrants
Common Stock
Convertible Notes
Common Stock
Additional Paid- In Capital
Convertible Notes
Additional Paid- In Capital
Retained Earnings (Deficit)
Pre-funded warrants
Convertible Notes
Total
Beginning Balance at Dec. 31, 2023     $ 1   $ 32,862 $ (33,131)     $ (268)
Beginning Balance (in shares) at Dec. 31, 2023     11,956,823            
Net loss           (21,495)     (21,495)
Equity-based compensation transactions, net         3,015       3,015
Equity-based compensation transactions, net (in shares)     186,408            
Equity line of credit commitment fee         500       500
Equity line of credit commitment fee (in shares)     171,821            
Issuance of common stock     $ 1   13,891       13,892
Issuance of common stock (in shares)     10,166,398            
Issuance of Pre-funded warrants         8,892       8,892
Conversion of convertible debt $ 1     $ 7,751     $ 1 $ 7,751  
Conversion of convertible debt (in shares) 6,602,439 1,442,163              
Ending Balance at Dec. 31, 2024     $ 3   66,911 (54,626)     12,288
Ending Balance (in shares) at Dec. 31, 2024     30,526,052            
Net loss           (11,713)     (11,713)
Equity-based compensation transactions, net         549       549
Equity-based compensation transactions, net (in shares)     2,866,893            
Issuance of common stock     $ 4   23,158       23,162
Issuance of common stock (in shares)     40,767,630            
Issuance of Pre-funded warrants         7,709       7,709
Conversion of convertible debt $ 1           $ 1    
Conversion of convertible debt (in shares) 6,100,000                
Settlement of vendor liability         36       36
Settlement of vendor liability (in shares)     43,956            
Ending Balance at Dec. 31, 2025     $ 8   $ 98,363 $ (66,339)     $ 32,032
Ending Balance (in shares) at Dec. 31, 2025     80,304,531